Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
93,644
-
Share change
-
-270,522
-
Total reported value
-
$7,450,815
-
Price per share
-
$79.11
-
Number of holders
-
11
-
Value change
-
-$21,177,846
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2025
As of 31 Dec 2025 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 93,644 shares of stock of the company.
Largest 10 holders included SG Americas Securities, LLC, Assenagon Asset Management S.A., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Significant Wealth Partners LLC, Wedmont Private Capital, PARK AVENUE SECURITIES LLC, Everhart Financial Group, Inc., GAMMA Investing LLC, Versant Capital Management, Inc, and MassMutual Private Wealth & Trust, FSB.
This table shows 11 institutional shareholders of the security as of 31 Dec 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.